- Home
- BGLC vs ELAB Comparison
BGLC vs ELAB Comparison
Compare BGLC & ELAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGLC
- ELAB
- Stock Information
- Founded
- BGLC 2017
- ELAB 2020
- Country
- BGLC Malaysia
- ELAB United States
- Employees
- BGLC N/A
- ELAB N/A
- Industry
- BGLC Medical Specialities
- ELAB
- Sector
- BGLC Health Care
- ELAB
- Exchange
- BGLC Nasdaq
- ELAB Nasdaq
- Market Cap
- BGLC 5.8M
- ELAB 6.6M
- IPO Year
- BGLC N/A
- ELAB 2023
- Fundamental
- Price
- BGLC $0.35
- ELAB $1.65
- Analyst Decision
- BGLC
- ELAB
- Analyst Count
- BGLC 0
- ELAB 0
- Target Price
- BGLC N/A
- ELAB N/A
- AVG Volume (30 Days)
- BGLC 177.5K
- ELAB 4.6M
- Earning Date
- BGLC 03-04-2025
- ELAB 03-28-2025
- Dividend Yield
- BGLC N/A
- ELAB N/A
- EPS Growth
- BGLC N/A
- ELAB N/A
- EPS
- BGLC N/A
- ELAB N/A
- Revenue
- BGLC $9,259,858.00
- ELAB $2,446,161.00
- Revenue This Year
- BGLC N/A
- ELAB N/A
- Revenue Next Year
- BGLC N/A
- ELAB N/A
- P/E Ratio
- BGLC N/A
- ELAB N/A
- Revenue Growth
- BGLC N/A
- ELAB 112.17
- 52 Week Low
- BGLC $0.21
- ELAB $1.60
- 52 Week High
- BGLC $1.20
- ELAB $166.00
- Technical
- Relative Strength Index (RSI)
- BGLC 46.44
- ELAB 39.27
- Support Level
- BGLC $0.33
- ELAB $1.60
- Resistance Level
- BGLC $0.40
- ELAB $1.80
- Average True Range (ATR)
- BGLC 0.02
- ELAB 0.11
- MACD
- BGLC -0.01
- ELAB 0.04
- Stochastic Oscillator
- BGLC 23.07
- ELAB 15.66
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.
About ELAB Elevai Labs Inc.
PMGC Holdings Inc advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.